{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T06:37:13Z","timestamp":1790836633410,"version":"4.1.0"},"reference-count":32,"publisher":"Springer Science and Business Media LLC","issue":"S7","license":[{"start":{"date-parts":[[2019,5,1]],"date-time":"2019-05-01T00:00:00Z","timestamp":1556668800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Bioinformatics"],"published-print":{"date-parts":[[2019,5]]},"DOI":"10.1186\/s12859-019-2730-8","type":"journal-article","created":{"date-parts":[[2019,5,1]],"date-time":"2019-05-01T00:03:08Z","timestamp":1556668988000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":19,"title":["Screening drug target combinations in disease-related molecular networks"],"prefix":"10.1186","volume":"20","author":[{"given":"Min","family":"Luo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianfeng","family":"Jiao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruiqi","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,5,1]]},"reference":[{"issue":"1","key":"2730_CR1","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/1471-2105-12-1","volume":"12","author":"BJ Yoon","year":"2011","unstructured":"Yoon BJ. Enhanced stochastic optimization algorithm for finding effective multi-target therapeutics. Bmc Bioinformatics. 2011; 12(1):1\u201311.","journal-title":"Bmc Bioinformatics"},{"issue":"10","key":"2730_CR2","doi-asserted-by":"publisher","first-page":"831","DOI":"10.1038\/nrd1202","volume":"2","author":"MA Lindsay","year":"2003","unstructured":"Lindsay MA. Target discovery. Nat Rev Drug Discov. 2003; 2(10):831\u20138.","journal-title":"Nat Rev Drug Discov"},{"key":"2730_CR3","doi-asserted-by":"publisher","first-page":"228","DOI":"10.1038\/msb.2008.60","volume":"4","author":"K Yang","year":"2008","unstructured":"Yang K, Bai HJ, Ouyang Q, Lai LH, Tang C. Finding multiple target optimal intervention in disease related molecular network. Mol Syst Biol. 2008; 4:228.","journal-title":"Mol Syst Biol"},{"key":"2730_CR4","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1016\/j.tips.2005.02.007","volume":"26","author":"P Csermely","year":"2005","unstructured":"Csermely P, Agoston V, Pongor S. The efficiency of multi-target drugs: the network approach might help drug design. TRENDS Phamacol Sci. 2005; 26:178\u201382.","journal-title":"TRENDS Phamacol Sci"},{"key":"2730_CR5","doi-asserted-by":"publisher","first-page":"942","DOI":"10.1038\/437942a","volume":"437","author":"S Frantz","year":"2005","unstructured":"Frantz S. Drug discovery: playing dirty. Nature. 2005; 437:942\u20133.","journal-title":"Nature"},{"issue":"3","key":"2730_CR6","doi-asserted-by":"publisher","first-page":"621","DOI":"10.1124\/pr.58.3.10","volume":"58","author":"TC Chou","year":"2006","unstructured":"Chou TC. Theoretical Basis, Experimental Design, and Computerized Simulation of Synergism and Antagonism in Drug Combination Studies. Pharmacol Rev. 2006; 58(3):621\u201380.","journal-title":"Pharmacol Rev"},{"key":"2730_CR7","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1038\/nrd2195","volume":"6","author":"H Kitano","year":"2007","unstructured":"Kitano H. A robustness-based approach to systems-oriented drug design. Nat Rrv Drug Discov. 2007; 6:202\u201310.","journal-title":"Nat Rrv Drug Discov"},{"issue":"12","key":"2730_CR8","doi-asserted-by":"publisher","first-page":"e1002323","DOI":"10.1371\/journal.pcbi.1002323","volume":"7","author":"XM Zhao","year":"2011","unstructured":"Zhao XM, Iskar M, Zeller G, et al.Prediction of Drug Combinations by Integrating Molecular and Pharmacological Data. PLoS Comput Biol. 2011; 7(12):e1002323.","journal-title":"PLoS Comput Biol"},{"issue":"7 Supplement","key":"2730_CR9","first-page":"0","volume":"13","author":"YY Wang","year":"2012","unstructured":"Wang YY, Xu KJ, Song J, et al.Exploring drug combinations in genetic interaction network. BMC Bioinformatics. 2012; 13(7 Supplement):0\u20130.","journal-title":"BMC Bioinformatics"},{"issue":"1","key":"2730_CR10","doi-asserted-by":"publisher","first-page":"20558","DOI":"10.1038\/srep20558","volume":"6","author":"XD Zhang","year":"2016","unstructured":"Zhang XD, Song J, Bork P, et al.The exploration of network motifs as potential drug targets from post-translational regulatory networks. Sci Rep-UK. 2016; 6(1):20558.","journal-title":"Sci Rep-UK"},{"issue":"S2","key":"2730_CR11","doi-asserted-by":"publisher","first-page":"S7","DOI":"10.1186\/1752-0509-4-S2-S7","volume":"4 Suppl 2","author":"Z Wu","year":"2010","unstructured":"Wu Z, Zhao XM, Chen L. A systems biology approach to identify effective cocktail drugs. Bmc Syst Biol. 2010; 4 Suppl 2(S2):S7.","journal-title":"Bmc Syst Biol"},{"issue":"6918","key":"2730_CR12","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1038\/nature01198","volume":"421","author":"Z Gu","year":"2003","unstructured":"Gu Z, Steinmetz LM, Gu X, et al.Role of duplicate genes in genetic robustness against null mutations. Nature. 2003; 421(6918):63\u20136.","journal-title":"Nature"},{"issue":"4","key":"2730_CR13","doi-asserted-by":"publisher","first-page":"370","DOI":"10.1038\/nbt0402-370","volume":"20","author":"B Schoeberl","year":"2002","unstructured":"Schoeberl B, Eichlerjonsson C, Gilles ED, et al.Computational modeling of the dynamics of the MAP kinase cascade activated by surface and internalized EGF receptors. Nat Biotechnol. 2002; 20(4):370.","journal-title":"Nat Biotechnol"},{"issue":"4","key":"2730_CR14","doi-asserted-by":"publisher","first-page":"400","DOI":"10.1016\/j.cbpa.2005.06.008","volume":"9","author":"P Rajasethupathy","year":"2005","unstructured":"Rajasethupathy P, Vayttaden SJ, Bhalla US. Systems modeling: a pathway to drug discovery. Curr Opin Chem Biol. 2005; 9(4):400\u20136.","journal-title":"Curr Opin Chem Biol"},{"issue":"1","key":"2730_CR15","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1124\/mol.66.1.70","volume":"66","author":"MH Sung","year":"2004","unstructured":"Sung MH, Simon R. In silico simulation of inhibitor drug effects on nuclear factor-kappaB pathway dynamics. Mol Pharmacol. 2004; 66(1):70\u20135.","journal-title":"Mol Pharmacol"},{"issue":"5","key":"2730_CR16","doi-asserted-by":"publisher","first-page":"563","DOI":"10.1038\/clpt.2008.129","volume":"84","author":"WC Hwang","year":"2008","unstructured":"Hwang WC, Zhang A, Ramanathan M. Identification of information flow-modulating drug targets: a novel bridging paradigm for drug discovery. Clin Pharmacol Ther. 2008; 84(5):563\u201372.","journal-title":"Clin Pharmacol Ther"},{"issue":"3","key":"2730_CR17","doi-asserted-by":"publisher","first-page":"e55","DOI":"10.1371\/journal.pcbi.0030055","volume":"3","author":"K Yang","year":"2007","unstructured":"Yang K, Ma W, Liang H, et al.Dynamic Simulations on the Arachidonic Acid Metabolic Network. Plos Comput Biol. 2007; 3(3):e55.","journal-title":"Plos Comput Biol"},{"issue":"S2","key":"2730_CR18","doi-asserted-by":"publisher","first-page":"S7","DOI":"10.1186\/1752-0509-4-S2-S7","volume":"4 Suppl 2","author":"Z Wu","year":"2010","unstructured":"Wu Z, Zhao XM, Chen L. A systems biology approach to identify effective cocktail drugs. Bmc Syst Biol. 2010; 4 Suppl 2(S2):S7.","journal-title":"Bmc Syst Biol"},{"key":"2730_CR19","doi-asserted-by":"publisher","first-page":"40752","DOI":"10.1038\/srep40752","volume":"7","author":"L Huang","year":"2017","unstructured":"Huang L, Jiang Y, Chen Y. Predicting Drug Combination Index and Simulating the Network-Regulation Dynamics by Mathematical Modeling of Drug-Targeted EGFR-ERK Signaling Pathway. Sci Rep-UK. 2017; 7:40752.","journal-title":"Sci Rep-UK"},{"issue":"3","key":"2730_CR20","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s10867-016-9414-7","volume":"42","author":"Y Liu","year":"2016","unstructured":"Liu Y, Li S, Liu Z, et al.Bifurcation-based approach reveals synergism and optimal combinatorial perturbation. J Biol Phys. 2016; 42(3):1\u201316.","journal-title":"J Biol Phys"},{"issue":"3","key":"2730_CR21","doi-asserted-by":"publisher","first-page":"621","DOI":"10.1124\/pr.58.3.10","volume":"58","author":"TC Chou","year":"2006","unstructured":"Chou TC. Theoretical Basis, Experimental Design, and Computerized Simulation of Synergism and Antagonism in Drug Combination Studies. Pharmacol Rev. 2006; 58(3):621\u201381.","journal-title":"Pharmacol Rev"},{"issue":"9","key":"2730_CR22","doi-asserted-by":"publisher","first-page":"458","DOI":"10.1038\/nchembio817","volume":"2","author":"JB Fitzgerald","year":"2006","unstructured":"Fitzgerald JB, Schoeberl B, Nielsen UB. orger PK: Systems biology and combination therapy in the quest for clinical efficacy. Nat Chem Bioc. 2006; 2(9):458\u201366.","journal-title":"Nat Chem Bioc"},{"key":"2730_CR23","first-page":"jpet.117.241604","volume":"362","author":"LC Sullivan","year":"2017","unstructured":"Sullivan LC, Chavera TA, Gao X, et al.Regulation of delta opioid receptor-mediated signaling and antinociception in peripheral sensory neurons by arachidonic acid-dependent 12\/15-lipoxygenase metabolites. 1. 2017; 362:jpet.117.241604.","journal-title":"1"},{"issue":"8","key":"2730_CR24","doi-asserted-by":"publisher","first-page":"1353","DOI":"10.1016\/0006-2952(83)90446-X","volume":"32","author":"PM Simmons","year":"1983","unstructured":"Simmons PM, Salmon JA, Moncada S. The release of leukotriene B 4, during experimental inflammation. Biochem Pharmacol. 1983; 32(8):1353\u20139.","journal-title":"Biochem Pharmacol"},{"issue":"11","key":"2730_CR25","doi-asserted-by":"publisher","first-page":"871","DOI":"10.1038\/nrd2381","volume":"6","author":"RP Araujo","year":"2007","unstructured":"Araujo RP, Liotta LA, Petricoin EF. Proteins, drug targets and the mechanisms they control: the simple truth about complex networks. Nat Rev Drug Discov. 2007; 6(11):871\u201380.","journal-title":"Nat Rev Drug Discov"},{"issue":"1","key":"2730_CR26","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1186\/s13104-015-1101-4","volume":"8","author":"KK Reddy","year":"2015","unstructured":"Reddy KK, Rajan VKV, Gupta A, et al. Exploration of binding site pattern in arachidonic acid metabolizing enzymes, Cyclooxygenases and Lipoxygenases. Bmc Res Notes. 2015; 8(1):152.","journal-title":"Bmc Res Notes"},{"issue":"5","key":"2730_CR27","doi-asserted-by":"publisher","first-page":"1585","DOI":"10.1039\/c2mb05503a","volume":"8","author":"C He","year":"2012","unstructured":"He C, Wu Y, Lai Y, et al.Dynamic eicosanoid responses upon different inhibitor and combination treatments on the arachidonic acid metabolic network. Mol Biosyst. 2012; 8(5):1585\u201394.","journal-title":"Mol Biosyst"},{"key":"2730_CR28","doi-asserted-by":"publisher","first-page":"786","DOI":"10.1016\/j.ejmech.2016.07.010","volume":"122","author":"N Eleftheriadis","year":"2016","unstructured":"Eleftheriadis N, Poelman H, Leus NGJ, et al.Design of a novel thiophene inhibitor of 15-lipoxygenase-1 with both anti-inflammatory and neuroprotective properties. Eur J Med Chem. 2016; 122:786\u2013801.","journal-title":"Eur J Med Chem"},{"issue":"24","key":"2730_CR29","doi-asserted-by":"publisher","first-page":"7882","DOI":"10.1021\/jm8010096","volume":"51","author":"D Wei","year":"2008","unstructured":"Wei D, Jiang X, Zhou L, et al.Discovery of Multitarget Inhibitors by Combining Molecular Docking with Common Pharmacophore Matching. J Med Chem. 2008; 51(24):7882\u20138.","journal-title":"J Med Chem"},{"issue":"7","key":"2730_CR30","doi-asserted-by":"publisher","first-page":"1931","DOI":"10.1039\/c3mb25605g","volume":"9","author":"S Gu","year":"2013","unstructured":"Gu S, Yin N, Pei J, et al.Understanding Traditional Chinese Medicine Anti-inflammatory Herbal Formulae by Simulating Their Regulatory Functions on the Human Arachidonic Acid Metabolic Network. Mol Biosyst. 2013; 9(7):1931\u20138.","journal-title":"Mol Biosyst"},{"issue":"23","key":"2730_CR31","first-page":"4494","volume":"42","author":"Y Gu","year":"2017","unstructured":"Gu Y, Zhang X, Chen YK, et al.Discover potential inhibitors of 5-LOX and LTA4H from Rhei Radix et Rhizoma, Notopterygii Rhizoma et Radix and Genitana Macrophyllae Radix based on molecular simulation methods. China J Chin Materia Medica. 2017; 42(23):4494\u2013502.","journal-title":"China J Chin Materia Medica"},{"issue":"9","key":"2730_CR32","doi-asserted-by":"publisher","first-page":"1902","DOI":"10.1093\/carcin\/bgl039","volume":"27","author":"Z Sun","year":"2006","unstructured":"Sun Z, Sood S, Li N, et al.Involvement of the 5-lipoxygenase\/leukotriene A4 hydrolase pathway in 7,12-dimethylbenz[a]anthracene (DMBA)-induced oral carcinogenesis in hamster cheek pouch, and inhibition of carcinogenesis by its inhibitors. Carcinogenesis. 2006; 27(9):1902\u20138.","journal-title":"Carcinogenesis"}],"container-title":["BMC Bioinformatics"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12859-019-2730-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12859-019-2730-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12859-019-2730-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,4,29]],"date-time":"2020-04-29T23:09:33Z","timestamp":1588201773000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcbioinformatics.biomedcentral.com\/articles\/10.1186\/s12859-019-2730-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,5]]},"references-count":32,"journal-issue":{"issue":"S7","published-print":{"date-parts":[[2019,5]]}},"alternative-id":["2730"],"URL":"https:\/\/doi.org\/10.1186\/s12859-019-2730-8","relation":{},"ISSN":["1471-2105"],"issn-type":[{"value":"1471-2105","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,5]]},"assertion":[{"value":"1 May 2019","order":1,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Not applicable.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Publisher\u2019s Note"}}],"article-number":"198"}}